Author Correction: Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia

• Mahmoud A. Bassal,
• Saumya E. Samaraweera,
• Kelly Lim,
• Brooks A. Benard,
• Sheree Bailey,
• Satinder Kaur,
• Paul Leo,
• John Toubia,
• Chloe Thompson-Peach,
• Tran Nguyen,
• Kyaw Ze Ya Maung,
• Debora A. Casolari,
• Diana G. Iarossi,
• Ilaria S. Pagani,
• Jason Powell,
• Stuart Pitson,
• Siria Natera,
• Ute Roessner,
• Ian D. Lewis,
• Anna L. Brown,
• Daniel G. Tenen,
• Nirmal Robinson,
• David M. Ross,
• Ravindra Majeti,
• Thomas J. Gonda,
• Daniel Thomas,
• Richard J. D’Andrea

Affiliations

Mahmoud A. Bassal

Harvard Stem Cell Institute, Harvard Medical School

Saumya E. Samaraweera

Centre for Cancer Biology, University of South Australia and SA Pathology

Kelly Lim

Discipline of Medicine, University of Adelaide

Brooks A. Benard

Hematology Division, Department of Medicine, Stanford Cancer Institute, Institute for Stem Cell and Regenerative Medicine, Stanford University

Sheree Bailey

Clinical and Health Sciences, University of South Australia

Satinder Kaur

Discipline of Medicine, University of Adelaide

Paul Leo

Diamantina Institute, Translational Research Institute

John Toubia

Centre for Cancer Biology, University of South Australia and SA Pathology

Chloe Thompson-Peach

Discipline of Medicine, University of Adelaide

Tran Nguyen

Centre for Cancer Biology, University of South Australia and SA Pathology

Kyaw Ze Ya Maung

Centre for Cancer Biology, University of South Australia and SA Pathology

Debora A. Casolari

Centre for Cancer Biology, University of South Australia and SA Pathology

Diana G. Iarossi

Centre for Cancer Biology, University of South Australia and SA Pathology

Ilaria S. Pagani

Precision Medicine Theme, South Australian Health and Medical Research Institute

Jason Powell

Centre for Cancer Biology, University of South Australia and SA Pathology

Stuart Pitson

Centre for Cancer Biology, University of South Australia and SA Pathology

Siria Natera

Metabolomics Australia, The University of Melbourne

Ute Roessner

Metabolomics Australia, The University of Melbourne

Ian D. Lewis

Adelaide Oncology & Haematology

Anna L. Brown

Centre for Cancer Biology, University of South Australia and SA Pathology

Daniel G. Tenen

Harvard Stem Cell Institute, Harvard Medical School

Nirmal Robinson

Centre for Cancer Biology, University of South Australia and SA Pathology

David M. Ross

Centre for Cancer Biology, University of South Australia and SA Pathology

Ravindra Majeti

Hematology Division, Department of Medicine, Stanford Cancer Institute, Institute for Stem Cell and Regenerative Medicine, Stanford University

Thomas J. Gonda

Clinical and Health Sciences, University of South Australia

Daniel Thomas

Discipline of Medicine, University of Adelaide

Richard J. D’Andrea

Centre for Cancer Biology, University of South Australia and SA Pathology